Finance

Beta
Lists
ARCH:CVE
Arch Biopartners Inc
CA$0.47
-3.09%
(-0.015) 1D
Jun 9, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for ARCH...
Open
CA$0.49
High
CA$0.49
Low
CA$0.47
Mkt. cap
31.60M
Avg. vol.
48.77K
Volume
20.29K
52-wk high
CA$1.94
52-wk low
CA$0.39
EPS
-CA$0.04
Beta
1.38
Shares outstanding
67.93M
Open
CA$0.49
High
CA$0.49
Low
CA$0.47
Mkt. cap
31.60M
Avg. vol.
48.77K
Volume
20.29K
52-wk high
CA$1.94
52-wk low
CA$0.39
EPS
-CA$0.04
Beta
1.38
Shares outstanding
67.93M
News stories
From sources across the web
About Arch Biopartners Inc
CEO-
Employees-
Founded1983
HeadquartersToronto, Ontario, Canada
SectorHealth care
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
158.08K
-
-
-
Cost of goods sold
114.74K
-138.14K
502.15K
43.30K
Cost of revenue
114.74K
-138.14K
502.15K
43.30K
Research and development expenses
-
-
-
118.21K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
184.49K
268.24K
178.75K
246.77K
Operating expense
241.22K
313.98K
958.41K
364.98K
Total operating expenses
355.96K
175.84K
1.46M
408.28K
Operating income
-197.88K
-175.84K
-1.46M
-408.28K
Other non operating income
-18.57K
-41.07K
-19.48K
-51.14K
EBT including unusual items
-242.33K
-269.76K
-1.56M
-521.01K
EBT excluding unusual items
-242.33K
-269.76K
-1.56M
-521.01K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-242.33K
-269.76K
-1.56M
-521.01K
Net profit margin
-153.30%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-58.87K
-62.29K
-85.16K
-52.23K
Net interest expenses
-58.87K
-62.29K
-85.16K
-52.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more